Paxil, Pregnancy and Birth Defects: Litigation Update
Bloomberg News has reported that GlaxoSmithKline, the manufacturer of the antidepressant prescription drug Paxil, has entered into settlements with nearly 200 families for a total of $1 billion. The families charged in lawsuits that Paxil caused birth defects.
Paxil, Paxil Oral Suspension, and Paxil-CR are trade names of the drug Paroxetine, which is a member of a class of drugs known as “selective serotonin reuptake inhibitors” (SSRIs). A 2005 study based on 3,500 pregnant women, linked Paxil to twice as many birth defects compared to other antidepressants when taken during the first three months of pregnancy.
The birth defects identified in the study included congenital defects, heart defects and persistent pulmonary hypertension of the newborn (PPHN), a potentially fatal disease.
If your child was born with birth defects and you were prescribed Paxil or other antidepressant drugs while pregnant, please contact our law firm to learn about your rights for no charge or obligation.
Related posts:
- Study ties common antibiotics with birth defects
- Plastic bisphenol A linked to female aggression
- Bayer Healthcare Pharmaceuticals Inc. to Update Yaz & Yasmin Warning Label
- Yaz Birth Control Dangers: Patient Death Probed By Swiss Agency
- Side Effects of Yaz, Yasmin, and Ocella Birth Control Pills Explained
